ReproUnion – Reproductive Medicine Across Borders

Challenge 1:

Improvement of Human Male Fertility

Challenge 2:

Optimizing Medically Assisted Reproductive Treatment

Challenge 3:

Securing Female Ovarian Function

Challenge 4:

Prevention of Infertility-related Morbidity

Challenge 5:

Fertility Awareness

Partnership Agreement signed for ReproUnion 2.0

ReproUnion 2.0 marks the beginning of a new research and innovation paradigm within reproductive medicine in Greater Copenhagen. With seven signatures on the formal agreement, the partnership stands ready to continuously use the regional innovation force, international collaboration partners, and the triple-helix structure as leverage in its effort to solve five major global reproductive challenges, which are of great individual and social concern.

”It is fascinating to see that ReproUnion has become a well-known brand among other European and even American researchers in reproductive medicine. This development is very positive and important in our efforts to include internationally leading research centers in the ReproUnion collaboration,” comments Aleksander Giwercman, Professor at Lund University and ReproUnion Executive Board member.

The signing partners are the Universities of Copenhagen, Lund and Malmö, Region Hovedstaden (DK), Region Skåne (SE), Ferring Pharmaceuticals and Medicon Valley Alliance.

Read the full news release here

News

Find out what’s going on & stay up to date.

Patient mobility agreement continues to offer cross-border reproductive treatments

January 24, 2020| News

One of the highlights for ReproUnion in 2019 was the renewal of the patient mobility agreement between the Capital Region of Denmark and... Read More → Patient mobility agreement continues to offer cross-border reproductive treatments

Collaboration needed to turn around the negative fertility trend

December 18, 2019| News

Regional Chairmen and Deans in Lund, Malmö and Copenhagen stand behind ReproUnion in this opinion article, which Dagens Medicin in Sweden... Read More → Collaboration needed to turn around the negative fertility trend

With 1000 young men enrolled, FEPOS is the world largest cohort to examine the fetal origin of adult semen quality

December 9, 2019| News

FEPOS investigates the possible causes between male infertility and what was passed on at the fetal stage, by paring samples from mothers... Read More → With 1000 young men enrolled, FEPOS is the world largest cohort to examine the fetal origin of adult semen quality

Events

See the upcoming events here!

Find out more

PhD defence: Assisted reproductive technology treatment and risk of death, ovarian and breast cancer

26 Feb 2:30 PM at Center for Health and Society (CSS), Room 1.1.18, University of Copenhagen

Patient Mobility Agreement

The success of the ReproUnion facilitated Patient Mobility Agreement between Denmark and Sweden may lay the foundation for more bilateral health services between the two neighboring countries.

In 2017, the Patient Mobility Agreement enabled childless couples with certain types of infertility problems to receive specialized treatment within a field of expertise that is not available in their home country in Malmö and Copenhagen area. Today, 40 Danish and Swedish patients have already made use of the patient mobility agreement.

Chairman of the Regional Council of Copenhagen, Sophie Hæstorp Andersen also believes that there are great benefits of cooperation with Sweden for both Danish and Swedish patients.